Washington University School of Medicine

Digital Commons@Becker
Outlook Magazine

Washington University Publications

2017

Outlook Magazine, Autumn 2017

Follow this and additional works at: https://digitalcommons.wustl.edu/outlook

Recommended Citation
Outlook Magazine, Autumn 2017. Central Administration, Medical Public Affairs. Bernard Becker Medical
Library Archives. Washington University School of Medicine, Saint Louis, Missouri.
https://digitalcommons.wustl.edu/outlook/191

This Article is brought to you for free and open access by the Washington University Publications at Digital
Commons@Becker. It has been accepted for inclusion in Outlook Magazine by an authorized administrator of
Digital Commons@Becker. For more information, please contact vanam@wustl.edu.

SAVING THE CENTRAL WEST END

UNDERSTANDING THE OPIOID CRISIS

AUTUMN 2017

OUTLOOK.WUSTL.EDU

SEEING THE

Invisible
Cellular imaging facility reshapes
biomedical research

outlook.wustl.edu

Outlook 1

MATTHEW JOENS WUCCI AND JEN WALKER HULTGREN LAB

FEATURES

9

Anchoring a community
A new book sheds light on how medical center visionaries
helped save the neighboring Central West End.
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Inside an epidemic
In surveying some 25,000 addicts, psychiatrist Ted Cicero, PhD,
has uncovered a series of factors leading to the current U.S.
opioid crisis.

COVER Center for Cellular Imaging

equipment reveals Staphylococcus aureus
bacteria (purple) on the surface of a
catheter. The bacteria release the enzyme
urease, which hydrolyzes urea resulting in
crystal formation (gold) and the protein
fibrinogen (teal). This helps protect the
bacteria from immune cells (tan) and
antibiotics. See page 21.
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Making the invisible visible
To keep Washington University at the forefront of biomedical
research, a one-stop shop provides access to the most
sophisticated microscopes, plus professional guidance in
experimental design, sample preparation and data analysis.
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William Danforth, MD, then vice
chancellor for medical affairs,
at the McDonnell Hall groundbreaking ceremony in 1967.
Danforth and others decided to
keep the medical center in the
city, even as the neighborhood
faltered. See page 9.

TIM PARKER

BERNARD BECKER MEDICAL ARCHIVES

Park rangers in Missouri are joining
the fight against the opioid epidemic.
Above, rangers listen as David Tan,
MD, chief of the emergency medical
services section, talks about the crisis.
Increasingly, overdoses are occurring in
public parks. See page 14.
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The Department of Ophthalmology has been
renamed in honor of John F. Hardesty, MD.
A $10 million gift from his daughter is funding
research and patient care and recognizing
Hardesty’s legacy of service. See page 30.
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Alzheimer’s, sleep connection

D

isrupting just one night of sleep
in healthy, middle-aged adults
causes an increase in amyloid
beta, a brain protein associated with
Alzheimer’s disease, according to a study
from the School of Medicine, Radboud
University Medical Centre in the Netherlands
and Stanford University. And a week of
tossing and turning leads to an increase in
tau, another brain protein that has been
linked to Alzheimer’s and other
neurological diseases.
“We think that perhaps chronic poor
sleep during middle age may increase the
risk of Alzheimer’s later in life,” said David
M. Holtzman, MD, the Andrew B. and
Gretchen P. Jones Professor, head of the
Department of Neurology and the study’s
senior author. These findings were
published July 10 in the journal Brain.
For this study, 17 healthy adults ages 35
to 65 with no sleep problems or cognitive
impairments wore a wrist activity monitor
for up to two weeks, which measured how
much time they spent sleeping.
Each participant also spent a night in
sleep rooms at the medical school, where
they wore headphones over the ears and
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scalp electrodes to monitor brain waves.
Half the participants were assigned to
have their sleep disrupted during the night.
Every time their brain signals settled into
the slow-wave pattern characteristic of
deep, dreamless sleep, the researchers sent
a series of beeps through the headphones,
gradually getting louder, until the participants’
slow-wave patterns dissipated and they
entered shallower sleep.
Slow-wave sleep is when neurons rest
and the brain clears away the molecular
byproducts of mental activity.
The next morning, the participants who
had been beeped out of slow-wave sleep
reported feeling tired and unrefreshed,
even though they had slept just as long as
usual. Each underwent a spinal tap so the
researchers could measure the levels of
amyloid beta and tau in the fluid
surrounding the brain and spinal cord.
A month or more later, the process was
repeated, except that those who had their
sleep disrupted were allowed to sleep
through the night undisturbed, and those
who had slept uninterrupted were
disturbed by beeps.

YOEL JU

Poor sleep leads to increase in Alzheimer’s-related brain proteins

Brain waves during slow-wave sleep, measured as
a study participant slept.
The researchers compared participants’
amyloid beta and tau levels after the disrupted
night to the levels after the uninterrupted
night. They found a 10 percent increase in
amyloid beta levels after a single night of
interrupted sleep, but no corresponding
increase in tau levels. However, participants
whose activity monitors showed they had
slept poorly at home for the week before
the spinal tap showed a spike in tau levels.
Yo-El Ju, MD, co-first author and an
assistant professor of neurology, said it is
unlikely that a night or even a week of poor
sleep has much effect on overall risk of
developing the disease. “The main concern
is people who have chronic sleep
problems,” Ju said.
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To blunt postoperative pain and reduce the need for opioid
drugs following surgery, anesthesiologists often give patients
low doses of the drug ketamine during operations.
But a new study led by anesthesiologists at the School of
Medicine and the University of Michigan Medical School
indicates that ketamine doesn’t lower pain levels or reduce
the need for pain-killing opioid drugs in the days after an
operation. Further, older patients who receive ketamine
during surgery are more likely to experience hallucinations
and nightmares in
the recovery room
and for several
days following
surgery.
The findings
are published
online May 30 in
the journal The
Lancet.
“We found
Anesthesiologists routinely give surgery patients low
that the current
doses of the drug ketamine.
practice of
giving low doses of ketamine to patients during surgery
is not having the desired effect,” said first author Michael
S. Avidan, MBBCh, the Dr. Seymour and Rose T. Brown
Professor of Anesthesiology at Washington University. “So
we need to determine whether higher doses might be more
effective, or we need to find alternatives to opioids.”
Avidan, with co-principal investigator George A. Mashour,
MD, PhD, an anesthesiology professor at the University of
Michigan Medical School, led a study aimed at evaluating
ketamine as a way to prevent delirium and other complications.
In previous research, Avidan had found that up to 20 percent
of older patients experienced delirium following surgery.
The researchers followed 672 surgery patients in four
countries: the U.S., Canada, India and South Korea. During
surgery, the patients — all at least 60 years of age — either
received no ketamine, a very low dose of the drug, or a
slightly higher dose. The doses of ketamine given in the
study are the doses routinely given to surgery patients
by anesthesiologists who want to lower patients’ levels of
postoperative pain.
Avidan said the fact that the study results were consistent
at different sites in different countries makes him confident
that current ketamine practices are not having the desired
effect on delirium and postoperative pain. He said clinicians
should reconsider the common practice of giving low doses
of ketamine during surgery.
outlook.wustl.edu

EMPOWERING WOMEN Incoming female residents in
internal medicine gather for a networking event sponsored by
the Forum for Women in Internal Medicine (FWIM). Created in
2014, FWIM supports the professional and personal development
of women trainees in the Department of Medicine. The group
hosts career workshops and lectures, facilitates mentoring
opportunities and fosters a sense of camaraderie.

To learn more, visit ghs.wustl.edu/fwim.html

Klein to head PhD training program
Robyn S. Klein, MD, PhD, a physician-scientist recognized
internationally for her work on the brain’s immune system,
has been named vice provost and associate dean for graduate
education for the Division of
Biology & Biomedical Sciences
(DBBS), effective Jan. 1.
Klein succeeds John H. Russell,
PhD, who is retiring but will
retain an appointment in
developmental biology, and
plans to revitalize the Office
of Postdoctoral Affairs.
Widely emulated for its
interdisciplinary approach to
Robyn S. Klein, MD, PhD
training PhD scientists, DBBS
crosses both the Danforth and Medical campuses. It brings
together about 525 faculty members from 37 departments in
the School of Medicine, Arts & Sciences and the School of
Engineering & Applied Science who teach and mentor some
500 graduate students, making it the largest PhD program at
the university.
As associate dean, Klein will set the direction of graduate
education at DBBS. She also will be the first associate dean
of graduate education to hold the title of vice provost, a
change in governance that recognizes the status of DBBS as
a universitywide academic endeavor. Klein intends to build
on the division’s strength in training young scientists, and
to prepare students for interdisciplinary careers that extend
beyond academic domains. Klein also plans to increase
recruitment of underrepresented students.

JAMES BYARD
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Study: Ketamine does not
reduce postoperative pain
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(From left) Davis, Johanson, Carothers and Grange.

Boy meets doctor who
named his rare condition
Matthew Carothers, 13, a patient with JohansonBlizzard syndrome, recently met the doctor who
discovered the extremely rare congenital condition.
Short and thin for his age, Carothers first came to
Washington University at age 5 for thyroid problems.
Geneticist Kathy Grange, MD, a professor of pediatrics,
recognized the syndrome, which causes pancreatic
insufficiency. With diagnosis and treatment, his quality
of life has greatly improved. Over the years, Grange
said she wished she could discuss Carothers’ medical
issues with Ann Johanson, MD, who co-named the
syndrome with mentor Robert Blizzard, MD, in 1972.
Unbeknownst to Grange, Johanson was living in the
St. Louis area. Upon realizing this through Facebook
connections, nurse practitioner Susan Davis invited
Johanson to the Medical Campus.

NEW ACADEMY MEMBERS In recognition of their
distinguished achievements in original research, L. David Sibley,
PhD (left), and David C. Van Essen, PhD, recently were elected to
the National Academy of Sciences. Election is considered one of
the highest honors accorded a U.S. scientist or engineer. Sibley, the
Alan A. and Edith L. Wolff Distinguished Professor of Molecular
Microbiology, is an expert on the cellular microbiology of parasites.
Van Essen, the Alumni Endowed Professor of Neurobiology, studies the
structure, function, development and evolution of the cerebral cortex.
4 Washington University School of Medicine

A child’s chance of developing Type 1 diabetes may
be influenced by the viruses that live in his or her gut,
according to a new study.
“We identified one virus that was significantly associated
with reduced risk, and another group of viruses that was
associated with increased risk of developing antibodies
against the children’s
own cells,” said
Herbert “Skip”
Virgin IV, MD,
PhD, the Edward
Mallinckrodt
Professor and head
of Pathology and
Immunology, and
the study’s senior
author. “It looks
like the balance of
these two groups
Herbert “Skip” Virgin IV, MD, PhD, talks with postof viruses may
doctoral researcher Dale Balce, PhD.
control the risk of
developing the antibodies that can lead to Type 1 diabetes.”
The findings suggest a way to predict, and maybe even
prevent, the life-altering diagnosis.
Type 1 diabetes develops as a two-step process. First,
people acquire antibodies against their own pancreatic cells
responsible for producing insulin, a hormone that allows
cells to absorb sugar from the bloodstream. Some children
generate the auto-antibodies but never develop disease.
In other children, however, the auto-antibodies signal an
attack by the body’s own immune system on the pancreas
that leads to Type 1 diabetes.
Virgin and colleagues examined stool samples obtained
from birth to age 3 from children whose genes put them at
high risk of developing Type 1 diabetes. They matched 11
children who went on to acquire auto-antibodies — five of
whom later developed Type 1 diabetes — with 11 children
who did not develop auto-antibodies or the disease.
A previously unknown virus related to circoviruses was
found in five of the 11 children who did not develop autoantibodies, but not in any of the children who did.
The researchers also found differences in a group of viruses
called bacteriophages that infect bacteria, not human cells.
Children carrying bacteriophages that target the Bacteroides
species — one of the major groups of intestinal bacteria —
were more likely to start down the path toward diabetes.
Autumn 2017
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Study links intestinal
viruses to diabetes
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Millions of Americans take
proton pump inhibitors for
heartburn, ulcers and other
gastrointestinal problems.

Popular heartburn drugs tied to higher death risk
Risk increases the longer the drugs are used

P

opular heartburn drugs called
proton pump inhibitors (PPIs) are
linked to a higher death risk, a new
study shows. This risk increases the longer the
drugs are used.
The research is published online July 3 in
the journal BMJ Open.
Doctors widely prescribe PPIs to treat
ulcers and other gastrointestinal problems.
PPIs, under brand names such as Prevacid,
Prilosec and Nexium, also are available over
the counter. Both PPIs and H2 blockers, another
class of drug, are prescribed for serious medical
conditions such as upper gastrointestinal
tract bleeding, gastroesophageal reflux
disease and esophageal cancer.
A kidney doctor by profession, senior
author Ziyad Al-Aly, MD, previously has
published studies linking PPIs to kidney
disease. Studies from unrelated groups have
associated PPI use with health problems
ranging from bone fractures to dementia.
outlook.wustl.edu

Al-Aly, first author Yan Xie, PhD, a data
scientist, and colleagues reasoned that,
cumulatively, these side effects may affect
the mortality rate of PPI users.
To find out, the researchers sifted through
millions of de-identified veterans’ medical
records in a database maintained by the
U.S. Department of Veterans Affairs. They
identified 275,933 people who had been
prescribed a PPI and 73,355 people prescribed
an H2 blocker between October 2006 and
September 2008, and noted how many died
and when over the following five years.
“No matter how we sliced and diced the
data from this large data set, we saw the
same thing: There’s an increased risk of death
among PPI users,” said Al-Aly.
Al-Aly and colleagues found a 25 percent
increased risk of death in the PPI group
compared with the H2 blocker group. Among
people taking the drugs for one to two years,

the risk to PPI users was nearly 50 percent
higher than that of H2 blocker users.
The researchers estimate that, for every 500
people taking PPIs for a year, there is one extra
death that would not otherwise have occurred.
Although the recommended treatment
regimen for most PPIs is short — two to eight
weeks for ulcers, for example — many people
end up taking the drugs for months or years.
“A lot of times people get prescribed PPIs
for a good medical reason, but then doctors
don’t stop it and patients just keep getting
refill after refill after refill,” Al-Aly said. “There
needs to be periodic re-assessments as to
whether people need to be on these.”
Over-the-counter PPIs contain the same
compounds as prescription PPIs, just at lower
doses. The Food and Drug Administration
recommends taking PPIs no longer than four
weeks before consulting a doctor.
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A new study shows that a particular gut microbe can prevent
severe flu infections in mice, likely by breaking down naturally
occurring compounds — called flavonoids — commonly
found in foods such as black tea, red wine and blueberries.
The research, conducted in mice by School of Medicine
scientists, also indicates that this strategy is effective in staving
off severe flu damage when the interaction occurs prior to
infection with the virus. This work also could help explain the
wide variation in human responses to influenza infection.
The study is published in the journal Science.
“For years, flavonoids have been thought to have protective
properties that help regulate the immune system to fight
infections,” said first author Ashley L. Steed, MD, PhD, an
instructor in pediatrics who treats intensive care patients at
St. Louis Children’s Hospital.
Previous evidence suggests that the gut microbiome may
be important in protecting against severe influenza infections,
so in this study, the researchers aimed to identify just what gut
microbes might provide that protection.
“We were able to identify at least one type of bacteria that
uses these dietary compounds to boost interferon, a signaling
molecule that aids the immune response,” said the study’s
senior author, Thaddeus S. Stappenbeck, MD, PhD, the Conan
Professor of Pathology & Immunology.
This prevented influenza-related lung damage in the mice. It
is this kind of damage that often causes significant complications
such as pneumonia in people.
As part of the study, the researchers screened human
gut microbes looking for one that metabolized flavonoids.
Stappenbeck and Steed identified one such microbe that
they suspected might protect against flu damage.
The microbe, called Clostridium orbiscindens, degrades
flavonoids to produce a metabolite that enhances
interferon signaling.
“The metabolite is called desaminotyrosine, otherwise
known as DAT,” Steed said. “When we gave DAT to mice and
then infected them with influenza, the mice experienced far
less lung damage than mice not treated with DAT.”
Next steps include identifying other gut microbes that may use
flavonoids to influence the immune system, as well as exploring
ways to boost the levels of those bacteria in people whose
intestines aren’t adequately colonized with those microbes.

6 Washington University School of Medicine

First of 10 expected BJC
Investigators named
Helen McNeill, PhD, is the first researcher named as a
BJC Investigator at the School of Medicine. The new
BJC Investigators Program aims to recruit scientists
who bring innovative approaches to major biological
quandaries and whose discoveries stand to inform new
ways of understanding disease and developing treatments.
McNeill, an international leader in the field of
developmental biology, is a professor in the Institute
of Medical Science and the Department of Molecular
Genetics, both at the University of Toronto. She is also a
senior investigator
at the LunenfeldTanenbaum Research
Institute, part of
the Sinai Health
System in Toronto.
Her appointment as
a BJC Investigator
and a professor of
developmental biology
begins Jan. 1.
Helen McNeill, PhD, is an international leader in
“We sought
the field of developmental biology.
candidates who had
already indelibly
changed their fields, whose discoveries will result in new
and fundamental shifts in scientific thinking and whose
laboratories will become a nidus for additional innovative
work across Washington University,” said David H.
Perlmutter, MD, executive vice chancellor for medical
affairs and dean of the School of Medicine.
The program is designed to specifically focus on
basic science and is inspired by the Howard Hughes
Medical Institute’s philosophy of investing in people with
exceptional creative talent. It plans to bring 10 renowned
researchers to the School of Medicine and the life sciences
ecosystem of St. Louis.
“This program represents another joint effort between
BJC and Washington University to help keep the school’s
biomedical research at the forefront of discovery,” said
Steven H. Lipstein, CEO of BJC HealthCare.
McNeill’s work is focused on understanding the
processes that govern how cells make contact and work
together to form the broader architecture of whole tissues,
both during development and adulthood. Her work —
spanning studies of fruit flies, mice and human genetic data
— has relevance for understanding birth defects, cancer and
diseases of specific organs, such as the kidney and lungs.
Autumn 2017

COURTESY OF HELEN MCNEILL

Gut microbes, flavonoids
protect against severe flu
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Flavonoids are commonly
found in foods such as black
tea, red wine and blueberries.

VIRGINIA KELLY

OUTmed

Supporting LGBTQ rights
To help LGBTQ faculty, staff and students develop networking
relationships and find mentors, the Department of Medicine
recently launched OUTmed. One of its first priorities was to create
OUTlist, a visible listing of medical school faculty, staff, house
staff and students who identify as members of the LGBTQ
community, and an ALLYlist of those who support LGBTQ rights
and equality. OUTmed is committed to bringing national best
practices in LGBTQ health care to the medical school. Left, OUTmed
supporters marched in the St. Louis PrideFest parade June 25.

Learn more at internalmedicinediversity.
wustl.edu/outmed

Malaria drug protects fetuses from Zika infection
Treatment prevents virus from crossing placenta to infect fetus, mouse study shows

outlook.wustl.edu

Zika, however,
not only can invade
the placenta, but it
can multiply there,
Mysorekar and others
have found.
To understand
how Zika breaches the
placenta, Mysorekar,
postdoctoral fellow
Bin Cao, PhD, and
colleagues infected
human placental cells
with the virus. Exposure
to the virus activated
genes related to
autophagy, they found.
However, when the
researchers treated the cells with drugs to
ramp up the autophagy pathway, the number
of Zika-infected cells increased. Drugs that
suppressed autophagy resulted in fewer
placental cells infected with Zika virus. In
other words, the virus spread more effectively
when the researchers dialed up the barrier
response, and performed more sluggishly
when they dialed it down.
Since hydroxychloroquine suppresses
the autophagy response, the researchers
questioned whether it also could protect
fetuses against Zika. The researchers dosed
BIN CAO

S

tudying pregnant mice, School of
Medicine researchers have learned
that the Zika virus infects the fetus
by manipulating the body’s normal barrier
to infection. Moreover, they showed that a
malaria drug can interfere with this process,
protecting the fetus from viral infection.
“We found that the malaria drug
hydroxychloroquine effectively blocks
viral transmission to the fetus,” said senior
author Indira Mysorekar, PhD, an associate
professor of obstetrics and gynecology
and of pathology and immunology. “This
drug already is used in pregnant women
to treat malaria, and we suggest that it
warrants evaluation in primates and women
to diminish the risks of Zika infection and
disease in developing fetuses.”
The findings are published in The
Journal of Experimental Medicine.
To protect the developing fetus from
infection, the body mobilizes robust defenses
that keep microbes from ever reaching the
fetus in the first place.
Mysorekar and others have shown that
autophagy — the cellular waste-disposal
pathway by which cells grind up debris,
unwanted organelles and invading microbes
— is an important part of the formidable
placental barrier to infection.

Left: The malaria drug chloroquine — a close relative
of hydroxychloroquine — prevents the Zika virus
(green) from growing in human placental cells (blue).
Right: The drug rapamycin prompted the virus to
grow rapidly.
Zika-infected pregnant mice with either
hydroxychloroquine or a placebo. They found
significantly less virus in the fetuses and
placentas from the mice that had received
hydroxychloroquine. In addition, these
placentas showed less damage and the
fetuses regained normal growth.
Outlook 7

HOWARD HUGHES FELLOWS Medical students
Rukayat Taiwo (left) and Connor Liu have been selected to
receive a year of mentored training with top biomedical
scientists through the Howard Hughes Medical Institute’s
Medical Research Fellows Program. Taiwo is one of seven
fellows to receive funding for a second year. She is analyzing
glioblastoma on a molecular level with mentors Albert H. Kim,
MD, PhD, and Joshua B. Rubin, MD, PhD. Liu is working with
mentor Gavin P. Dunn, MD, PhD, to test computational strategies
that may be used to design therapeutic cancer vaccines.

TIM PARKER

Dean emeritus to lead University
of Hawaii faculty practice
Larry J. Shapiro, MD, dean
emeritus of the School of
Medicine, is the new chief
executive officer of University
Health Partners of Hawaii, the
faculty practice at the University
of Hawaii John A. Burns School
of Medicine.
A pediatrician, genetics
researcher and mentor, Shapiro
Larry J. Shapiro, MD
served as executive vice chancellor
for medical affairs and dean of the School of Medicine from
2003 to 2015. “Serving Washington University School of
Medicine has been an enormous privilege,” Shapiro said.
“It is a remarkable place, with many amazing and talented
individuals who work, study and teach here. I have been
associated with Washington University for more than 50
years as a student, a parent and a faculty member. I owe an
enormous debt to the many people that have meant so much
to me during that span of time.”
Shapiro said he plans to return to St. Louis often and
represent the university in Japan for the McDonnell
International Scholars Academy.
8 Washington University School of Medicine

Eva Aagaard, MD, formerly a professor of medicine and
associate dean for educational strategy at the University
of Colorado School of Medicine, has been named senior
associate dean for education.
“Eva is a visionary
with a glowing
reputation nationally
and internationally
for her leadership and
innovation in medical
education,” said David H.
Perlmutter, MD, executive
vice chancellor for
medical affairs and dean
of the School of Medicine.
Aagaard succeeds
Alison J. Whelan,
MD, who joined the
Eva Aagaard, MD
Association of American
Medical Colleges (AAMC) as its new chief medical
education officer. Mary E. Klingensmith, MD, the Mary
Culver Distinguished Professor of Surgery and vice chair
for education in the Department of Surgery, served as senior
associate dean for education in the interim.
At the University of Colorado, Aagaard founded the
Academy of Medical Educators, which works to promote
teaching excellence through faculty certificate programs in
medical education and leadership, one-on-one coaching, a
longitudinal and online curriculum for faculty development
and a residents-as-teachers program, among other initiatives.
Aagaard also directed the Center for Advancing Professional
Excellence, a standardized patient and simulation center.
Aagaard has served in national leadership positions with
the American Board of Internal Medicine, National Board
of Medical Examiners and the Society of General Internal
Medicine. In those roles, she has collaborated with the
AAMC and the Accreditation Council for Graduate Medical
Education. A noted mentor for women in medicine, Aagaard
works with dozens of committees and programs nationally
and at the university level. “Mentoring women is important
because they often lack access to mentors,” she said. “Having
a trusted colleague to help pinpoint priorities and identify
ways to achieve goals can help them overcome unique
challenges.”
She and her husband, Russ Aagaard, a small-business
owner, have two children.
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Medical education
leader appointed

EXPLORE ST. LOUIS

MISSOURI HISTORY MUSEUM

Anchor

How medical center visionaries helped save the Central West End

Top: Over a century old, the Central West
End, which abuts Washington University
Medical Campus, is full of charming cafés,
galleries, antique shops, restaurants
and boutiques. A new book outlines the
neighborhood’s origins, period of affluence,
decline and revitalization. Bottom: Delmar
Boulevard and Taylor Avenue in 1916.
outlook.wustl.edu
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Compton and Dry’s view of St. Louis, 1875

Q&A

with the author

Candace O’Connor has written extensively on
the history of the university and the medical
center. Among many others, her books
include: “Beginning a Great Work: Washington
University in St. Louis, 1853–2004,” “A Surgical
Department of Distinction: 100 Years of
Surgery at Washington University School of
Medicine,” “Imaging & Innovation: A History
of Mallinckrodt Institute of Radiology,”
“Hope and Healing: St. Louis Children’s
Hospital” and the forthcoming “A Legacy of
Caring: The History of Barnes-Jewish Hospital.”

10 Washington University School of Medicine

A

n ambitious new book traces the rise, fall and resurrection
of the Central West End, the historic neighborhood
near Washington University Medical Campus.
Impetus for the book came from William H. Danforth,
MD, university chancellor from 1971 to 1995 and former
vice chancellor for medical affairs. Danforth said he felt it
was important to highlight the medical center’s crucial role
in saving its own neighborhood and staying in the city even
as crime escalated and the area faltered.
“Renaissance: A History of the Central West End” is a
320-page coffee table book written by St. Louis author
Candace O’Connor and published by Reedy Press.

Autumn 2017

As the medical school and its affiliate hospitals
grew and prospered, what was happening in the
neighborhood around it?
During the teens, 1920s and into the 1930s, the CWE
flourished. Prominent people, such as David Francis
— who was chief World’s Fair organizer, St. Louis
mayor, Missouri governor and ambassador to Russia
— lived in giant houses, staffed by uniformed
servants. At Kingshighway and Lindell, the William
Bixby family owned the entire block and lived in
a palatial home that later was demolished to make
way for the elegant Chase and Park Plaza hotels.

WELLS FARGO

When and why did the downturn in the
neighborhood begin?

What was the Central West End like before the
School of Medicine was built?
By the time the new Washington University
School of Medicine campus was dedicated in 1915,
the Central West End (CWE) was by far the most
desirable neighborhood in St. Louis. In 1875, when
Compton and Dry created their famous bird’seye views of the city, the CWE had been a sleepy,
rural place, mostly farmland. But in the run-up to
the 1904 World’s Fair, and in the booming years
afterward, that changed dramatically. High-end
builders developed beautiful streets, including
private places, along with chic commercial districts.
Robert Brookings, the university board chairman
who moved the medical school from downtown
St. Louis to Kingshighway, bought a home for
himself on Lindell, across from Forest Park.
Religious congregations moved in, as did other
hospitals. Many of the city’s elite settled in CWE
houses, including such noted School of Medicine
physicians as Washington Fischel, George Gellhorn,
W. McKim Marriott, Evarts Graham and Vilray
Blair. A 1912 book, published by a local newspaper,
listed the 4,000 most famous men in St. Louis —
and most of them lived in the CWE.
outlook.wustl.edu

In 1927, a powerful tornado devastated parts of
the CWE, killing 78 people and injuring 500. On
many days, a pall of smoke, caused by coal fires and
industrial pollution, hung over the area, and some
residents began to look toward new suburbs with
cleaner air. During the 1930s-era Depression, some
of the large homes became unaffordable. Then at the
end of World War II, the crush of returning soldiers
created a huge demand for housing. Suddenly, owners
had a great incentive to break up these large homes
into rooming houses. In the 1950s and 1960s, some
mansions were torn down for modern high-rises or
even parking lots.

What was the Central West End’s low point?
By the 1960s and early 1970s, the situation in
the CWE had become critical. As Dr. Ron Evens
(former head, Mallinckrodt Institute of Radiology,
and former president, Barnes-Jewish Hospital)
said: “People don’t realize when you go to the
CWE now, what it was like then. It was seedy. It
was dirty. It was high crime. It was prostitutes.
It was people drunk on the streets. So the issue
became, ‘Oh, my God, what are we going to do
about that?’” Dr. Will Ross (nephrologist and
associate dean) said that when he was here for
a medical school interview, he was walking
down Kingshighway when a policeman behind
him began shooting at a man in front of him.
In 1962, the medical center institutions banded
together, forming the organization later called the
Washington University Medical Center. Still crime
was a serious problem for employees, who were
being robbed on the streets. Other hospitals —
St. John’s, Shriners, Missouri Baptist and St. Luke’s
— started moving out of the area.
Outlook 11

What did the medical center try next?
They needed a new approach. So Dr. Danforth,
who became university chancellor in 1971, had
lunch with developer Richard Roloff, then working
for Capitol Land Company, and he generously
agreed to take on volunteer leadership of a new
revitalization effort. He did a spectacular job,
though it was tough going. At his first meeting
with residents, he encountered a crowd still
angry from the newspaper article. As he recalled,
every one of those people would cheerfully have
bought him a one-way ticket to California! But
he persisted, hiring urban design firm Team
Four to devise a plan that would save as much
historic architecture as possible, acquire homes
from residents ready to leave and re-sell them to
12 Washington University School of Medicine

How does the future look for the Central West End
and surrounding neighborhoods?
The future of the CWE is very bright, and its
success also has been a catalyst for growth in other
neighborhoods. The Forest Park Southeast area,
now known as The Grove, began a major renewal
under the leadership of William Peck, then dean
of the medical school, and Dr. Jerry Flance, who
worked with residents and urban pioneers. And
the new Cortex Innovation Community, a 200-acre
technology district to the east, developed there in
part because startup businesses liked the proximity
to the medical center and to the diverse, exciting
CWE. Today, Cortex is one of the fastest growing
technology startup scenes in the U.S., with more
than 250 companies on site. So the WUMCRC’s
valiant efforts in the 1970s and beyond have
certainly had a wide-reaching impact.
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It was extraordinarily successful. The Washington
University Medical Center Redevelopment
Corporation (WUMCRC) — headed successively
by executive directors Jerry King, Eugene Kilgen
and others — worked in partnership with area
residents and the medical center, particularly
psychiatrist Dr. Samuel Guze, who succeeded
Dr. Danforth as vice chancellor for medical
affairs. They bought up dilapidated homes, such
as those on the 4300 and 4400 blocks of Laclede;
often the elderly owners would greet them at the
door and say gratefully, “Where do I sign?” Then
they attracted young families — even the new
superintendent of the St. Louis schools — to buy
and rehab them. A diverse group of people moved
in. They also encouraged new businesses to come
in. Of course, the medical school and the hospitals
have since thrived and grown substantially, with
more than 20,000 people working there daily. One
surprise has been that the WUMCRC, initially
viewed as a decade-long effort, continues today
under executive director Brian Phillips. The CWE
now is a vibrant mix of historic buildings and new
development.

LEFT: BECKER MEDICAL ARCHIVES

“That decision (to stay) may be one of
the five most important decisions ever
made in terms of the history of the city
of St. Louis. Because if the Washington
University Medical Center had left … can
you imagine what the city of St. Louis
would be like?” — Jerry King

How successful was this revitalization effort?

RIGHT: COURTESY OF CORTEX

During the 1960s, Dr. William Danforth, then
vice chancellor for medical affairs, began to worry
about the flight of these hospitals and the fancy
new “Palaces on Ballas” they were building in the
western suburbs. He tapped the talented young
Dr. Evens to head a committee that would consider
three options: move the medical center west,
stay put, or remain in place but build a clinical
presence in the Plaza Frontenac area. Raymond
Wittcoff (developer and Jewish Hospital board
member) was a major advocate for staying in the
city, and ultimately that view prevailed. Next
Wittcoff contacted an architectural firm to design
a plan for the Central West End. But the proposal
called for razing a huge swath of the area — and
somehow it was leaked to a local newspaper.
People living in the neighborhood, who were
working hard to save it, were horrified.

young buyers, eager to renovate. He and his team
also brought in a major client, Blue Cross, to new
headquarters that later became the 4444 building
on Forest Park Avenue.

LEFT: WASHINGTON UNIVERSITY IN ST. LOUIS PHOTOS

What did Washington University Medical Center
do about it?

Art gallery in William Bixby’s palatial home, c. 1904

Dr. Carl Moore lectures in Barnes Amphitheater, 1943
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World Chess Hall of Fame, 2015

Dilapidated buildings with Grand Avenue skyline in background, 1961

Dining today in the Central West End
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Solae/DuPont Headquarters in Cortex Innovation Community, 2010

Inside an epidemic
Overcoming America’s opioid crisis starts with
understanding abuse patterns
BY GAIA REMEROWSKI

Theodore Cicero’s research changed direction when he encountered a
20-year-old who was taking opioids — but not to get high.
The young man was struggling with depression, low self-esteem and
social anxiety. He was taking drugs because he believed they made him a
better, more popular person. He was more social, more relaxed and was
able to approach women in bars and start conversations. And he was taking
opioids despite the disastrous consequences he knew they could have.
Cicero, PhD, the John P. Feighner Professor of Psychiatry, has surveyed
25,000 addicts on why they use drugs. It’s stories like the young man’s that
illuminate the challenge medical professionals face in fighting drug use.
14 Washington University School of Medicine
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For more than 25 years,
psychiatrist Theodore
Cicero, PhD, has been
on the leading edge of
the opioid epidemic,
surveying some 25,000
addicts around the country.

How did we get here?

he typical survey response is not that they
are getting high, but that it relieves their
depression, they feel less anxious,” Cicero
said. “Many people feel they are actually better
individuals when they’re taking drugs because they
are more outgoing. People think they function better.
That’s a difficult thing to combat.”
This is the power opioids, such as the prescription
pain pill oxycodone or the more easily obtained
illegal heroin, have on many individuals and is one
major reason the drugs are so addictive. In 2014,
drug overdoses surpassed automobile accidents
as the No. 1 cause of accidental death for the first
time in U.S. history. And although not all of these
overdoses are due to opioids, 91 Americans die
every day from an opioid overdose, according to
the Centers for Disease Control and Prevention
(CDC). CDC data also show that 60 percent
of overdoses occur in patients with legitimate
prescriptions from a single doctor.
For 25 years, Cicero has been ahead of this
developing crisis, charting addicts’ motivations
and predicting emerging abuse patterns around
the country. Cicero and colleagues were the first
to identify changing demographics as opioid
addiction spread from inner cities to the suburbs,
and also predicted the shift from painkillers to
heroin to synthetic opioids like fentanyl.
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“There are two events that happened in the late
’90s and early 2000s that have led to where we are
right now,” Cicero said.
In 2001, the Joint Commission accrediting
organization, advocating on behalf of patients,
issued a set of standards outlining how the healthcare industry was vastly undertreating pain. The
report recommended that health-care workers
consider pain as the “fifth vital sign,” along with
monitoring of a patient’s temperature, pulse,
respiration and blood pressure.
As a result, health-care workers routinely began
asking patients to rate their pain on a pain scale.
The overarching message: patients shouldn’t have
to endure pain.
The report also urged physicians to prescribe
opioids more freely, based on a letter published
in 1980 in The New England Journal of Medicine
(NEJM). Written by two doctors, the five-sentence
letter stated: “We conclude that despite widespread
use of narcotic drugs in hospitals, the development
of addiction is rare in medical patients with no
history of addiction.” Though the letter since has
been debunked, drug makers and doctors still
cite it as a reason to continue the widespread
prescribing of opioids.
Another event that took abuse to a critical level
was the 1996 introduction of an extended-release
version of oxycodone, one of the most popular
opioid painkillers.
Sold under the brand name OxyContin, the
new pills could be taken just once or twice a day,
rather than every 4 to 6 hours. “For people who
had trouble keeping track of their medications,
this was an ideal solution,” Cicero said. “Elderly
people, for example, especially have memory
issues with that.”
This new formulation, however, also was an
ideal solution for addicts. For a pill to work over
24 hours, it must contain a large amount of the
active drug. Instead of 5 mg, each tablet now
contained 80 to 100 mg of oxycodone. Addicts
soon learned they could release the drug’s full
potency all at once by crushing the new tablets.
The revised formulation also contained
no acetaminophen or non-steroidal antiinflammatory drugs, both of which make
snorting and injecting the drug very painful.
(Acetaminophen, for instance, burns the nasal
passages when snorted.)
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From pain pills to heroin
How misunderstandings and good intentions
drove the worst drug crisis in U.S. history

MISINFORMATION

PAIN SCALE

A now-debunked letter in
The New England Journal
of Medicine deems painkillers
as rarely addictive.

The Joint Commission suggests
pain is vastly undertreated and
urges doctors to consider it as
the “fifth vital sign.”

OPIATE EXPLOSION
Doctors prescribe larger amounts of opioids,
which end up on the street. An extendedrelease version of OxyContin containing
10 times more active ingredient is developed,
making it easier to crush and snort.

SUPPLY LIMITS

DETERRENCE EFFORTS

As doctors realize the
abuse potential, they limit
prescriptions, decreasing
supply and increasing costs
of opioids on the streets.

Drug company makes a version of
OxyContin that is more difficult to
crush and snort. This inadvertently
drives addicts to heroin.

HEROIN
The epidemic increases over
time. Addicts’ demographics shift
from poor, predominantly black
communities to more white, middleto upper-class communities.

FENTANYL

?

Dealers realize cutting heroin with the
far more potent, cheaper, lab-made
opioids fentanyl and carfentanil gives
users a better — but often fatal — high.
outlook.wustl.edu
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David Tan, MD (standing),
chief of the emergency medical
services section, explains
naloxone administration to
Missouri park rangers at
Babler Memorial State Park
in Wildwood. Naloxone, or
Narcan, is a nasal spray that
works as an opioid antidote.
Frontline responders, such as
highway patrol officers, park
rangers and conservation
agents, now keep Narcan at
their disposal.

“Now all of a sudden we had a pure version
of oxycodone that didn’t contain any additives,”
Cicero said. The maker of this extended formula
and the Food and Drug Administration (FDA)
later stated that they did not foresee addicts’
workarounds.
With a new emphasis on curing pain and
the discovery of a more potent delivery method,
other pharmaceutical companies began producing
variations of these pain pills. Doctors became
more willing to prescribe opioids in larger
amounts. Many of these prescriptions would go
unused, stored in medicine cabinets and end up
getting stolen, sold and diverted to the streets.
“Now you have a ready supply of it on the street
because physicians were doing their job and
treating pain, but had no indication that this
was going to lead to trouble,” Cicero said.

Gathering abuse data
In the 1990s, Cicero worked on an FDA advisory
committee evaluating the abuse potential of
drugs undergoing approvals. Before long, a drug
company sought his help in gaining federal
approval for a new opioid named tramadol, or
Ultram. To determine its abuse potential, Cicero
suggested sending surveys to U.S. drug treatment
centers for patients to confidentially complete.
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Center directors would not read these surveys;
instead, responses would go to Cicero’s research
group at the School of Medicine. This helped
legitimize the project and prompted addicts to be
more forthcoming with their answers.
“Addicts felt the survey was for a good purpose
and that we were trying to solve a problem that
they had,” Cicero said. “They’re desperately
looking for someone who will either help them
with their treatment or maybe prevent this crisis
in the first place.”
Over the past two decades, Cicero’s team
has sent out confidential questionnaires to
approximately 150 drug treatment centers
nationally to better understand addiction. Most
clients choose to remain anonymous, but some
agree to be identified and even participate in
lengthier interviews with Cicero.
Survey data is collected in real time. This
enables the researchers to put their “ears to the
ground,” identify new types of drug abuse and
quickly inform regional first responders and
agencies about impending threats.
“I don’t think there’s anyone that does a
more thorough and accurate survey of drug
abuse than Ted Cicero,” said John Burke, past
president of the National Association of Drug
Diversion Investigators and a retired Ohio police
commander who served on the force more than
50 years. He now runs Pharmaceutical Diversion
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Overdose antidote

Narcan is an antidote that rapidly reverses the effects of an opioid overdose;
it has no adverse effects if administered to a person who is not overdosing.
The drug is available at many pharmacies without a prescription.

OPIOIDS

NALOXONE NARCAN

OPIOID
RECEPTORS IN
THE BRAIN

for signs of an
overdose
1Check

Signs include: lack of responsiveness, shallow breathing, pinpoint
pupils, blue/gray lips or fingernails,
clammy/pale face. Call 911.

2 Administer Narcan

If, based on these signs, you suspect
an overdose, administer Narcan nasal
spray in one nostril. The spray is
absorbed through the blood vessels
in the nasal membranes.

Education Inc., an organization that educates
law enforcement and health professionals about
the dangers of diversion (the illegal theft and sales
of pharmaceutical drugs).
Cicero’s studies helped verify opioid abuse
trends in Ohio, a state hit particularly hard by
this crisis. The findings “over and over are
consistent with what we see on the street,” Burke
said, and have been a reliable source for educating
the public about the changing face of opioid abuse.
Cicero and his colleagues also publish survey
data and analyses in national scientific journals
and keep the FDA abreast of their findings. While
the agency collects its own data, the gathering
process extends over much longer time periods
and is often published years later.

A new drug of choice
When doctors realized the NEJM letter was wrong
and that there actually was a very large abuse
potential for painkillers, they began limiting the
quantity of pills they prescribed. Purdue Pharma
also switched to an abuse-deterrent formulation of
OxyContin that was much more difficult to crush
and snort. These changes kept some of the pills
off the streets and slowed their abuse but had the
unintended consequence of forcing addicts, who
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3 Monitor response

The drug then travels to the brain, where
it replaces the opioid molecules that
are bound to opioid receptors. Narcan
works to revive victims in 2-5 minutes.
If needed, administer second dose.

were unlikely to stop using drugs altogether, to
find a substitute. That substitute, for the most
part, was heroin.
In 2014, Washington University was the first
to signal this shift from prescription opioids to
heroin, a cheap and easily accessible alternative.
As more people used heroin, the less stigmatized
it became. Suddenly heroin started showing up
in affluent suburban neighborhoods and schools.
Cicero’s surveys uncovered these shifts in users’
demographics: Half of those who began using
heroin before 1980 were white, but over the past
decade nearly 90 percent of those who began
using were white.
The surveys also helped reveal the use of
fentanyl, a synthetic opioid, which began to show
up in much of the heroin responsible for overdoses,
and carfentanil, a derivative of fentanyl that is
used to tranquilize elephants. Fentanyl and its
derivatives are 50 to 100 times more potent than
heroin, provide a more intense “high” for the user
and are relatively inexpensive to make in the lab.
Knowing fentanyl and similar drugs
were becoming a problem has helped federal
authorities to better monitor availability and
block importation of the drugs into the country.
First responders also have learned to use caution
as some of these drugs can be deadly — even in
small amounts — if accidently inhaled at the
scene of an overdose.
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Moving beyond fear
All of this misuse has had a chilling effect on
doctors, who now may be resistant to prescribing
opioids, even to those who need them. “Physicians
are really at a disadvantage now not knowing
who to treat and who not to treat,” Cicero said.
“Given all the publicity surrounding this problem,
and now the escalation to heroin, most physicians
have gotten to the point where they’re afraid to
prescribe these medications.”
Doctors must learn to ask questions about
patients’ previous history of drug use, alcohol
use and smoking, as well as any past anxiety or
depression, Cicero said. These are all potential
markers of abuse. Cicero also believes physicians
need to be more cognizant about the amount of
opioids they are prescribing: Is a 30-day supply
really necessary in most cases?

“Physicians are really at a disadvantage
now not knowing who to treat and
who not to treat.” — Theodore Cicero, PhD
To help improve opioid prescribing practices,
Cicero suggests that medical schools add opioid
and alternative pain management, as well as
addiction education, to the curriculum. Medical
students graduating today generally are not
equipped to deal with the crisis.
“Most physicians don’t really know how to
effectively treat pain. We don’t teach them,” Cicero
said. “They don’t know how to manage pain and they
certainly don’t know the signs that a potential patient
is going to be vulnerable or susceptible to abuse.”
Evan Schwarz, MD, assistant professor of
emergency medicine, and his team are on the
frontlines, treating at least two to three addicts a
night in the Barnes-Jewish Hospital Emergency
Department (ED). When possible, the team
administers Suboxone, a medication that limits
cravings, as part of a project funded by the
Behavioral Health Network of Greater St. Louis.
General practitioners can undergo training to
learn how to administer Suboxone and similar
addiction treatment drugs, Schwarz said. This way,
they can treat regular patients who show signs of
opioid abuse on an outpatient basis, which could
help relieve the strain on treatment centers.
20 Washington University School of Medicine

Providing patients with realistic pain
management expectations can go a long way
in preventing addiction, Schwarz said. Zero
pain may not be achievable and patients may
need to endure some measure of pain in certain
circumstances. When appropriate, physicians
and patients should seek out alternative forms
of pain control via pain management specialists,
physical therapists, meditation and so forth.
“We try to let patients understand that we’re
going to do our best to control their pain and give
them realistic expectations for what we can do,”
he said. “And even if we’re prescribing opioids,
we want to do it in a safe and limited way because
these medications do have risks.”
Washington University emergency physicians
David Tan, MD, and Jeffrey Siegler, MD, also
are leading regional medical training for first
responders on naloxone administration. Naloxone,
or Narcan, works as an opioid antidote, reversing
an overdose within seconds. Narcan has saved
nearly 27,000 lives, according to the CDC.
The training is part of a federal grant from
the Substance Abuse and Mental Health Services
Administration, in partnership with the National
Council on Alcoholism and Drug Abuse.
The program educates first responders about
misconceptions surrounding opioids. “Some
people, when they start the training, are sitting
there with a scowl on their face, with their arms
crossed,” said Tan, also chief of the emergency
medical services section. “And they think that these
heroin addicts can choose to stop like we choose to
stop at a red light and go at a green light. And it’s
just not that easy for many of these people.”
To help prevent repeat overdoses, something
the responders see all too often, the training also
emphasizes the importance of referring addicts to
treatment centers, Tan said.
Even with treatment, though, it is not easy
to recover from opioid addiction. “The average
number of times our patients have been in
treatment is 4.8, almost five times,” Cicero said.
“And some people are sober for years and then
slip back into it because that feeling that they get
with this drug — how it makes them feel like a
better person — is going to be with them forever.
“The ability to understand this, to get
qualitative data has turned out to be extremely
important. And we’re now on the leading edge
of being able to use these data methods to
understand more about what motivates abuse
and how to mitigate it.”
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Making the
invisible visible
Imaging center brings
the science of life to light
BY TA M A R A B H A N DA R I

Cells near the edge of a mouse
kidney glow red, a sign that they
are starved for oxygen. This is an
important clue for researchers
studying how the kidney responds
to injury. Image taken on Zeiss
Axioscan Z1 Automated Slide
Scanning System.
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welve feet tall and weighing several tons,
the microscope capable of generating the
voltage of a stun gun looms over James
Fitzpatrick, PhD, as he circles it, deftly opening
latches and detaching panels. A door on the side
swings open, revealing a tangle of wires and, near
the top, a shelf the size of a tape cassette. When the
machine is fully built and turned on, a robotic arm
will reach down, pick up experimental samples
placed on the shelf and insert them into a column
deep inside. There, the samples will be bombarded
with electrons.
And the invisible will be unveiled.
This instrument that Fitzpatrick has so painstakingly unsealed is a top-of-the-line cryo-electron
microscope. It is capable of magnifying the living
world’s tiniest structures — bacteria, viruses and
biomolecules — a million or more times, bringing
the unimaginably small up to a human scale.

“It’s a complicated beastie,” said Fitzpatrick,
grinning. He is director of the Washington
University Center for Cellular Imaging, known
as WUCCI and pronounced Wookiee.
He has spent the better part of the spring and
summer overseeing the installation and calibration
of the $7.2 million microscope, and he will put it
through weeks of testing before making it available
to the center’s clients later this fall. The machine
is the cornerstone of a significant investment
in cellular imaging. Advances in the field are
transforming biomedical research, and WUCCI is
keeping Washington University at the forefront.

Introducing the WUCCI
WUCCI sprawls across 6,000 square feet in the
basement of the McKinley Research Building (to
be renamed the Debra and George W. Couch III
Biomedical Research Building) on the Medical
Campus. It houses 15 of the most advanced
microscopes, as well as banks of high-powered
computers that are needed to analyze the
mountains of data they produce.
The scopes can take 3-D images of viruses, make
movies of living neurons as they signal one another,
visualize the beating hearts of small animals
such as worms and fish and map the structure of
proteins down to the location of each atom.
Since the center’s establishment in 2015,
researchers have imaged everything from living
zebrafish and butterfly eyes to plastic catheters
and rocks.
Today, more than 500 Washington University
researchers representing some 220 labs use the
center, and Fitzpatrick is hoping to draw more.

Cornerstone of biology

TIM PARKER

When Anton van Leeuwenhoek looked through
the first microscope more than 300 years ago and
saw legions of previously unimagined life forms
wriggling underneath, he established one of the
foundations of modern biology.
“Imaging is one of the cornerstones of biology
and biomedical science,” said Azad Bonni, MD,
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James Fitzpatrick, PhD, adjusts the wiring inside the center’s
new cryo-electron microscope. The instrument visualizes objects
as small as a few billionths of a meter, allowing researchers to
map the location of each atom in a protein.
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PhD, the Edison Professor and chair of the
Department of Neuroscience. “Whatever
questions we’re trying to answer, it all comes
down to cells, because they are the fundamental
unit of living things.”
Modern research microscopes are as far
from Leeuwenhoek’s single-mounted lens as
smart phones are from Alexander Graham Bell’s
invention. They not only take snapshots of cells
mounted on slides, they can record movies of a
fertilized egg developing into an embryo, or of an
immune cell chasing a bacterium. They can focus
deep inside bones, tumors and even small animals,
allowing scientists to see cells and tissues in their
natural environment. They reveal our DNA.
Microscopy makes the invisible visible.
WUCCI builds on the strengths of the
departments of Neuroscience and of Cell Biology
and Physiology, which operated separate imaging
facilities for a number of decades. About five years
ago, at funding renewal time, department leaders
questioned whether to re-establish separate facilities
or join together. “It occurred to us that it might be
a good idea to create a collaborative center greater
than the sum of its parts,” Bonni said.
The neuroscience imaging facility specialized
in light microscopy, which allows researchers to
attach fluorescent markers to specific molecules or
cells, color-coding their images. Such technology
suits researchers who often study how cells respond
to cues, and circuits of cells and the synapses
connecting them.
outlook.wustl.edu

Cell biologists lean more heavily on electron
microscopy, which images objects tens to thousands
of times smaller than cells. Electron microscopes
reveal precisely how the essential molecular
machinery of the cell operates and how molecules
involved in disease might be targeted with drugs.
Members of both departments — Paul Taghert,
PhD, and Bonni from Neuroscience, and Helen
Piwnica-Worms, PhD, Robert Mecham, PhD,
David Piston, PhD, and Phyllis Hanson, MD, PhD,
of Cell Biology and Physiology — advocated for
this core center and engaged in discussions across
the medical school. Taghert and Hanson traveled
the country, gathering the best ideas from leading
imaging facilities. Ultimately, Fitzpatrick was
recruited from The Salk Institute in San Diego.
“We sold him on the idea that he could build
something big here,” Bonni said.

To study how sound is
transmitted from the ear to
the brain, researchers stained
specialized sound-detecting
cells (blue) and their synapses
(red/green) in a mouse inner
ear. Image taken on Zeiss LSM
880 Airyscan Microscope.

Institutional resource
Modern imaging is key to understanding and
treating many diseases. Thirty years ago, there
were no microscopes that could map the blood
vessels inside a solid tumor, or trace the outlines
of each molecule in a virus’s shell. That technology
now hums and clicks and reshapes medicine in
Fitzpatrick’s center, and researchers increasingly
rely on it. With every technological improvement,
microscopy has grown more central to biological
research … and more expensive.
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Imaging life

Modern microscopes can image objects
ranging in size from insects to molecules.
1cm
XRAY
MICROSCOPY
X-rays can penetrate
deep into the body to
image internal organs,
tissues and whole
small animals such as
worms and insects.

ORGANISM

1mm

TISSUE

LIGHT
MICROSCOPY
The oldest form of imaging,
light microscopy illuminates
tissues, cells and some
bacteria. Molecular labels
that fluoresce in every color
of the rainbow allow
researchers to color-code
their images.

CELL

“Many researchers need access to a wide
range of imaging tools but could never afford to
have them in their lab,” said Piston, the Edward
Mallinckrodt Jr. Professor and head of Cell
Biology and Physiology. “Often that means that
young investigators have to make compromises
on their choice of projects, but having access to
WUCCI allows them to think more broadly.”
Furthermore, effectively using the high-tech
equipment requires skills that can be difficult for
small research groups to obtain.
“As the technology becomes more complicated,
it takes more and more specialized expertise to
get the most out of it,” Piston said. “In a large
central facility, we can afford to hire and train
the right specialists.”
Fitzpatrick likes to call the facility a one-stop
shop, because the seven full-time staff members
— all scientists themselves — are prepared to
help with any stage of research.
“I have sat down with people at WUCCI and
talked about basic cell biology,” said Clifford
Luke, PhD, an associate professor of pediatrics
who has used the center’s super-resolution light
microscopes. “If you tell them what question
you’re trying to answer, they will help you figure
out the best way to do the experiment and which
microscope is best suited for it.”
WUCCI has a suite devoted to sample
preparation, containing equipment such as
diamond knives sharp enough to cut extremely
thin slices of tissue. Just as sets for TV shows

1µm

Electron microscopes use
a concentrated beam of
electrons to visualize the
very smallest objects –
bacteria, viruses, molecules,
even atoms.

1nm

MATTHEW JOENS WUCCI AND KEL VIN WOO ORNITZ LAB

BACTERIA

ELECTRON
MICROSCOPY

PROTEIN

UNIT OF MEASUREMENT
1 cm = 1 centimeter =1/100 of a meter
1 mm =1 millimeter =1/1,000 of a meter
1 µm =1 micrometer=1/1,000,000 (millionth) of a meter
1 nm =1 nanometer =1/1,000,000,000 (billionth) of a meter
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X-ray tomography detects an emulsion of gold
nanoparticles, tracing the network of blood vessels
in a mouse’s lungs and heart. Image taken on Zeiss
Versa 520 X-Ray Microscope.
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became more realistic as high-definition TVs
became commonplace, sample prep has become
more important — and more elaborate — as
microscopy has improved.
“When the resolution wasn’t as good, the
quality of the sample prep didn’t matter as much,”
Fitzpatrick said. “If something was a bit distorted,
you couldn’t tell. These days, the quality of sample
prep is of paramount importance.”
Immense computing power is required to
process the complex datasets that come off the
microscopes. Powerful computers line one wall of
the center, and center staff can assist with analysis.

WUCCI is the latest step in a long history of
imaging strength and innovation at Washington
University. The first electron microscope built in
the U.S. was designed and constructed by Gordon
H. Scott, PhD, associate professor of cytology in
the Department of Anatomy, around 1935.
More recently, Timothy Holy, PhD, the Alan
A. and Edith L. Wolff Professor of Neuroscience,
developed a form of light-sheet microscopy, which
allows scientists to view thousands of cells at a
time. Holy used this variation on the technique to
scan more than 10,000 cells in a mouse’s nose to
find the rare ones that turn on when the animal
sniffs a particular pheromone.
Now, WUCCI staff are pushing the next
frontier of imaging: virtual reality.
“We have microscopes that produce these
beautiful, detailed 3-D images, but then we
display them on a flat 2-D screen,” Fitzpatrick
said. “We think that if people can take their
results, hold them in their hands, turn them
around, and look at them from all angles it will
generate new ideas and understanding.”
Michael Shih, PhD, a center research specialist,
has begun developing software that can convert
researchers’ 3-D images into a virtual reality. The
goal is to create an immersive environment to
navigate biological samples ranging in scale from
molecules to organ systems.
Although a virtual still image allows
researchers to manipulate and inspect a virtual
object, a virtual reality movie would allow
people to watch from the inside as a biological
process took place. Imagine standing at a cell’s
midline and watching as the chromosomes lined
up around you and then pulled apart into two
daughter cells.
outlook.wustl.edu
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Pushing the limits

“Hardly anyone is working on the applications
of virtual reality in microscopy,” Fitzpatrick said.
“This is something we are working on offering that
no other imaging facility can do.”

Wearing a headset and hand
controllers, Michael Shih, PhD,
explores the virtual reality
scene he has created from a
researcher’s 3-D still image.

Looking ahead
WUCCI has the potential to transform how
biology is done at Washington University. The
center ranks among the top five best in the U.S., as
measured by the quality of the microscopes and the
power of the computers. Staying in that position
requires an ongoing commitment. Increasingly,
other departments are contributing specialized
equipment. The cryo-electron microscope, for
instance, was jointly purchased by the offices of
the provost and the medical school dean and other
medical school departments led by Biochemistry &
Molecular Biophysics and Cell Biology & Physiology.
“More and more, biomedical research depends
on new technology,” Piston said. “There has
been a lot of expertise in imaging at Washington
University for a long time, but it has been
distributed in different departments and centers,
and it was difficult for researchers to find all the
parts they might need, or to even learn that those
were available. “With WUCCI, we now have the
ability to access the newest technology through
shared contributions.”
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Edison Family

T

Fund supports

research that improves human health.

Advancing
human
health

gut microbiome

BY MARY LEE

research

he advent of genomic medicine
has created the need for a new type
of scientist — one able to translate

genetic data into clinically relevant
For nearly 15 years, the interdisciplinary
Center for Genome Sciences & Systems
Biology at the School of Medicine has
provided a fertile proving ground for this

Jeffrey Gordon, MD, studies
the microbial communities
that colonize the human gut.
His work has revolutionized
understanding of how gut
microbes shape human health
and disease. Talented students
and postdoctoral researchers
such as Carrie Cowardin, PhD
(left), and Vanderlene Kung, MD,
PhD, assist him.
26 Washington University School of Medicine
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new breed of investigator.
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Groundbreaking research
Gordon is internationally recognized for his
pioneering role in establishing a field of research
devoted to the human microbiome. His work
focuses on the trillions of microbes that live in
the gut, where they process foods and synthesize
vitamins and nutrients that human cells can’t
manage on their own. Groundbreaking studies by
Gordon and his trainees have linked these microbes
and their genes to disease and good health.
After initially identifying the
relationship between dysfunctional
gut microbiomes and obesity more
than a decade ago, Gordon and his
students expanded their research to
address childhood malnutrition, the
leading cause of death worldwide in
children under the age of 5. They have
formulated new types of food-based
therapies that are designed to repair
the gut microbiota in malnourished
children. Working with collaborators
in Bangladesh, they are beginning
to test the effectiveness of these
therapeutic foods.
“This gift from the Edison
Foundation will enable us to make
strategic investments that allow our
research community to evolve and
remain vibrant,” Gordon said. “I think
Harry Edison
it is a wonderful expression of trust on
the part of the Edison family. Their belief in our
center and our capacity to improve the health and
well-being of people around the world encourages
us to keep moving forward, especially in a time of
uncertainty regarding federal funding for research.”

EDISON FOUNDATION

Working at the interface of computational
and experimental biology, the center’s faculty
members and students have developed novel
approaches to address some of the world’s
greatest health challenges, including obesity,
childhood malnutrition and antibiotic resistance.
To help advance the center’s innovative
research and training programs, a St. Louis
family with a long history of investing in the
School of Medicine has contributed $10 million
to Washington University. This gift from the
Edison family through the Harry Edison
Foundation will create the Edison Family Fund
to support the Center for Genome Sciences &
Systems Biology and the work of its director,
Jeffrey Gordon, MD, the Dr. Robert J. Glaser
Distinguished University Professor. In recognition,
the center is being named the Edison Family
Center for Genome Sciences & Systems Biology.
“This gift will serve as an important catalyst
for the School of Medicine’s personalized medicine
initiative,” said Chancellor Mark S. Wrighton.
“It will enhance our efforts to understand how
our genetic differences influence our well-being
and disease risk and empower a new generation of
scientists to combat illnesses that affect millions.”
The Harry Edison Foundation’s first gift to the
School of Medicine, made in 1967, established
a professorship in surgery as a tribute to the
foundation’s namesake. Harry Edison, one of
five brothers who founded a chain of shoe stores
that became the fashion conglomerate Edison
Brothers Stores, was a noted philanthropist
and civic leader.
“For 50 years, the Edison family has been
committed to supporting St. Louis’ greatest
institutions, including Washington University
and its School of Medicine,” said Andrew
Newman, Harry Edison’s great-nephew, a
trustee of the Harry Edison Foundation and
a longtime member of the university’s Board
of Trustees and member of the School of
Medicine National Council. “We are excited
to play a role in advancing the important work
being done at the Center for Genome Sciences
& Systems Biology. I have known Jeff Gordon
for many years, and I have great confidence in
his leadership and research.”

Family’s legacy
Previous gifts from the Harry Edison Foundation
have supported a variety of initiatives and
programs at the School of Medicine, including
diabetes research, stem cell and developmental
biology research, and the construction of the Eric
P. Newman Education Center, named in honor
of Andrew Newman’s father, a 1935 graduate
of Washington University’s School of Law. The
foundation also established a second professorship —
the Edison Professorship in Neurobiology — in 1977.
Members of the Edison family have provided
significant personal support and leadership across
the university for many years.
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David Schlessinger

Paul S. Simons

Col. Thomas R. Burklow

J. William Campbell

Gary A. Ratkin

Alumni Association awards
Each year, the Washington University Medical Center Alumni Association
honors a select group of graduates, faculty members, former residents
and fellows for their professional achievements, community service and
dedication to the university. Here are the 2017 recipients:
To read more about
the recipients, go to

wumcnews.org/
2017awards

n

David Schlessinger, PhD

n

Paul S. Simons, MD ’67

Distinguished Service Award

Distinguished Service Award

Schlessinger is a National Institutes of Health
(NIH) Distinguished Investigator at the
Laboratory of Genetics at the National
Institute on Aging (NIA). He is internationally
recognized for his pioneering work in basic
molecular biology, including the mechanism
of action of antibiotics and the application
of human genetics and genomics to better
understand disease.
In 1960, Schlessinger earned a doctoral
degree from Harvard University, where he
worked for DNA co-discoverer and Nobel
laureate James Watson. Following two years
of postdoctoral training at the Pasteur Institute,
Schlessinger joined Washington University,
where he served as professor of molecular
microbiology, of genetics and of microbiology
until 1997.
Schlessinger firmly established the study
of human genetics at Washington University
and is credited with positioning the school at
the forefront of genetics research before he later
moved to the NIA.

Simons, associate professor of pediatrics, is
known throughout the pediatric community
for his tireless dedication to the treatment of
children and adolescents with developmental
and behavioral disabilities.
Long before autism and attention deficit
disorder (ADD) were in the national spotlight,
Simons not only was identifying and treating
children with these disabilities, he also was
training numerous medical students and
residents in developmental and behavioral
pediatrics.
A devoted advocate of his patients, Simons
also championed research, contributing
heavily to the enrollment of clinical research
subjects into research protocols at Washington
University. The field of pediatrics has benefited
greatly from the school’s psychiatric studies of
depression, autism, bipolar disease and ADD.
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Charles W.M. Roberts

n

n

Jeff M. Michalski

Scot G. Hickman

Thomas R. Burklow, MD ’87

n

Faculty Achievement Award

Burklow, director for Population Health and
HEDIS Compliance at Walter Reed National
Military Medical Center, was recognized for
30 years of outstanding service as a clinical,
academic and administrative leader in the
nation’s flagship military centers.

Hickman, a professor of medicine, is renowned
for outstanding mentorship of medical students,
residents and junior faculty. He has taught
the hematology section of the medical school
curriculum for 30 years and the oncology
section for 20. Many students say he inspired
them to become hematologists and oncologists.

J. William Campbell, MD ’77, HS ’80
n

Michalski, the Carlos Perez Distinguished
Professor of Radiation Oncology, is a global
leader in the treatment of prostate and
pediatric cancers. He was honored for his
important contributions to radiation oncology
and to the improvement of patient care at
the Alvin J. Siteman Cancer Center.

Gary A. Ratkin, MD ’67, HS ’72
n

McCallum is professor and founding chair of the
Department of Internal Medicine at Texas Tech
University Health Sciences Center and chief of
its Division of Gastroenterology, Hepatology
and Nutrition. He is recognized as a premier
thought leader in neurogastroenterology and
gastrointestinal motility.

Charles W. M. Roberts, MD/PhD ’95
Alumni Achievement Award
Roberts is director of the Comprehensive
Cancer Center and executive vice president
at St. Jude Children’s Research Hospital
in Memphis. An international expert in
cancer epigenetics and a dedicated pediatric
oncologist, colleagues regard him as an
accomplished leader who moves seamlessly
from research to clinical care.
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Richard W. McCallum, MBBS, HS ’72
Resident/Fellow Alumni Achievement Award

Ratkin, an associate professor of clinical
medicine, is a distinguished oncologist, medical
ethicist and palliative care physician. His ideas
regarding living longer and better through
palliative care have served as the basis for
teaching how to care for chronically ill patients.
n

Jeff M. Michalski, MD, HS ’91
Faculty Achievement Award

Campbell is medical director for St. Luke’s
Medical Group and professor of clinical
medicine at the School of Medicine. Among
the earliest physicians in St. Louis to treat
patients with HIV/AIDS, Campbell helped
establish the medical school as a leading center
for care of HIV-infected patients.

Alumni Achievement Award

Janet B. McGill

Scot G. Hickman, MD ’70, HS ’77

Alumni Achievement Award

Alumni Achievement Award

n

Richard W. McCallum

n

Janet B. McGill, MD, HS ’87
Resident/Fellow Alumni Achievement Award
McGill, a professor of medicine, has
made important contributions to further
the understanding and management of
diabetes mellitus. She has led more than 200
clinical trials and helped develop the most
recent American Association of Clinical
Endocrinology diabetes treatment guidelines.
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Shining B
example

y all accounts, St. Louis ophthalmologist
John Franklin Hardesty, MD (1887-1953),
was a hero. As a member of the U.S. Army

Medical Corps during World War I, he risked his
life to help soldiers on the front lines. After the war,
he sent assistance to Polish and Russian soldiers he

Ophthalmology department
named for John Hardesty

met while being held as a prisoner of war in

BY MARY LEE

in need and advocated for laws to benefit the blind.

Germany. And as a physician, he helped pioneer
glaucoma treatments, provided free care to those
“When he died, so many people came to his
funeral,” said Jane Hardesty
Poole, AB ’61, Hardesty’s
daughter. “Some of his patients
were in tears because he had
saved their or their child’s
eyesight. My mother
and I had no idea
he had helped so

MISSOURI HISTORY MUSEUM, ST. LOUIS

many people.”

30 Washington University School of Medicine

During World War I, Hardesty
(seated) helped several soldiers
escape from a prisoner of war camp
in Villingen, Germany. One of the
men, Edouard Issacs (right), who
changed his surname to Izac, went
on to become a U.S. Congressman
from California.
Autumn 2017

To honor her father’s memory and legacy
after he was honorably discharged from the
of service, Poole has committed $10 million to
Army. He devised a successful plan to distract
the Department of Ophthalmology and Visual
guards and short-circuit lighting along a
Sciences. In recognition, the department will be
barbed-wire fence so three fellow prisoners
renamed the John F. Hardesty, MD, Department
could make their way through it. The Germans
of Ophthalmology and Visual Sciences.
never discovered his role in the plot. For his
“Our department has a long history of
heroism, Hardesty received the Victory Medal.
advancing understanding of eye diseases and
Hardesty was a faculty member at Saint
vision loss, particularly in the area of glaucoma,” John Hardesty, MD
Louis University Medical School from 1920
said Todd Margolis, MD, PhD, the Alan A. and
until his death, and also served as acting chair
Edith L. Wolff Distinguished Professor and department
of its ophthalmology department.
chair. “It is fitting that the department now will bear the
In 1934, he wrote a thesis for membership in the
name of a man whose life’s work involved preserving vision
American Ophthalmological Society that proposed a new
and improving the quality of life for glaucoma patients.”
way to treat glaucoma using systemic medications such as
The gift will support ophthalmology research, clinical
epinephrine. His research represented the first attempt to
care and innovative training programs, and will help the
treat glaucoma in this way. Epinephrine in eye drop form
department recruit and retain outstanding physician-scientists.
still is used to treat the disease. Hardesty’s work laid the
One of 12 children, Hardesty was born in Winfield,
foundation for the development of the oral drug Diamox
Missouri. He earned bachelor’s and medical degrees from
for glaucoma in the 1950s by Washington University
Saint Louis University in 1914, and completed an internship
ophthalmology professor Bernard Becker, MD.
and residency at St. Louis City Hospital. He had just begun
Hardesty provided free eye care to residents of the Blind
to practice medicine in St. Louis when the U.S. entered
Girls’ Home, Missouri School for the Blind and other schools
World War I in April 1917.
and orphanages, and to patients throughout the region.
After joining the U.S. Army Medical Corps, Hardesty
Poole, who was only 14 when her father died, remembers
was among the earliest group of surgeons to volunteer to
him as a kind and loving man. “I adored him,” she said.
serve with the British Army as a member of the Seaforth
“We would walk down to dinner every night on our wide
Highlanders, an infantry regiment associated with the
staircase with our arms around one another. He gave me the
northern Highlands of Scotland. During a fierce battle in
unconditional love that every child needs.”
northwest France, the German Army captured Hardesty
“My father was modest and humble,” Poole added. “He
while he was manning an aid post on the frontline trenches.
wanted to be a doctor simply to help people. On top of his
For eight months, he was held as a prisoner of war.
great ability, he gave freely of his time and resources. He
Hardesty’s role in a daring escape from the Villingen
stands as a shining example of what every doctor should be.”
camp in October 1918 was widely reported in newspapers

Professor saved eyesight
of donor’s daughter

I

n 2012, Jane Hardesty Poole established the John F. Hardesty, MD,
Distinguished Professorship in Ophthalmology and Visual Sciences, now
held by pediatric ophthalmologist R. Lawrence Tychsen, MD. Poole credits
Tychsen with saving her daughter Josephine’s eyesight.
Born with a developmental disability, Josephine is non-verbal and
could not articulate what she was seeing on traditional eye tests. After
consulting many doctors near their Manhattan home, Poole read an article
in The New York Times highlighting novel ophthalmology treatments at
Washington University. In 2004, she and her daughter traveled to St. Louis
to meet Tychsen. Through surgery, he restored her vision to 20/40.
The experience convinced Poole that Washington University was
the appropriate place to honor her father. “I want to honor him where
it’s the best,” she said. — Hilary Davidson
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R. Lawrence Tychsen, MD, and Jane Hardesty Poole
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Celebrating
100 years
BY HILARY DAVIDSON

MICHELE BERHORST

Cindy Mach, MSOT/MPH/S ’17,
right, practices functional
transfers and safe patient
care in an acute care setting,
while teaching assistant
Brianna Beattie, OTD/S ’17,
acts as her patient.

Centennial challenge supports scholarships in occupational therapy
is turning 100 years old in 2018. To celebrate,
Carolyn Baum, PhD, OTR, FAOTA, the program’s
Elias Michael Executive Director, has created a scholarship
challenge. All gifts to the Occupational Therapy annual
fund will be matched by the $100,000 Carolyn Baum
Centennial Challenge, which runs through Dec. 31, 2018.
“At our 100th anniversary, the future of occupational
therapy has never looked brighter,” Baum said.
Baum said she hopes the challenge will inspire alumni
and friends to make a special gift, ensuring that the best
and brightest students become the health-care leaders
of tomorrow.
“The Baum Centennial Challenge lays the groundwork for another 100 years of superlative teaching and
research at the Program in Occupational Therapy,” said

“At our 100th anniversary,
the future of occupational
therapy has never looked
brighter.” — Carolyn Baum, PhD
32 Washington University School of Medicine

David H. Perlmutter, MD,
executive vice chancellor for
medical affairs and dean of
the School of Medicine.
To learn more, visit
medicalalumni.wustl.edu/
baumcentennialchallenge.

About Carolyn Baum
Baum, a professor of
occupational therapy,
neurology and social work,
has led the occupational
Carolyn Baum, PhD
therapy program since 1988.
Her interdisciplinary perspective
has helped guide the program, which U.S. News &
World Report ranks as No. 1 in the nation. In 2017, the
American Occupational Therapy Association named Baum
as one of 100 influential people who have shaped the field
of occupational therapy.
Baum earned a bachelor’s degree in occupational therapy
from the University of Kansas, a master’s degree in health
management from Webster University, and a doctorate in
social work from the Brown School at Washington University.
Autumn 2017
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CLASSNOTES

Find your friends.
Classnotes are organized first by
year of degree/training completion
and then in alphabetical order.

How about you?
Share your news via the online
form at wumcnews.org/classnotes.
Submissions will be printed in
a subsequent issue of Outlook
magazine as space allows. Photos
are welcome.

1950 S
Emil Mantini,
MD ’58, and his
wife, Jane Mantini,
NU ’57, moved to
Tampa, Fla., where
they enjoy living
in an active senior
center and watching
sailboats gather in the bay once a week.
They have three grown children: sons Franz
and Louis, who live in Tampa and northern
Florida, respectively, and daughter
Elizabeth, who lives in the St. Louis area.
The family recently gathered in Tampa
to celebrate the couple’s 60th wedding
anniversary.

1960 S
Robert D. Porter, MD ’67, retired from
nephrology practice in Topeka, Kan. In
2013, he received the Bal Jeffrey Award
for advancing medical care in northeast
Kansas. Porter continues to serve as a senior
Federal Aviation Administration aeromedical
examiner and as a short-term medical
provider to the Karen people along the
Thai-Burma border. He is also a regular
volunteer at the Abilene and Smoky Valley
Railroad in Abilene, Kan.
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Virginia Crandall, NU ’69, returned to
work, providing women’s health care two
days a week at a private practice in Colorado
Springs, Colo. She also enjoys traveling and
recently took a bike tour of New Zealand with
friends and her daughter and son-in-law.

1970 S
Thomas H. Gee,
HA ’78, recently was
recognized for 25 years
of service as the chief
executive officer of
Henry County Medical
Center in Paris, Tenn.
Gee serves on the
Board of Directors of the Tennessee Hospital
Association and as an alternate delegate to
the American Hospital Association. In 2016,
Governor Bill Haslam appointed Gee to the
Tennessee State Board for Licensing of Health
Care Facilities.
Stephen Young, MD
’78, was elected to the
National Academy of
Sciences in 2016 for his
research on plasma lipid
metabolism and diseases
of the nuclear envelope.
He is a cardiologist and
distinguished professor of medicine and
human genetics at the David Geffen School
of Medicine at UCLA.

1980 S
Molly Eaton, MD ’81, spent more than 30
years in Atlanta and is moving to Denver
to serve as associate professor in infectious
diseases at the University of Colorado Health
Sciences Center, Anschutz Medical Campus.
David Pfeffer, MD ’83, is president of The
Virginia Urological Society. He also serves
as the Virginia State Society representative
to the American Association of Clinical
Urologists. He would like to encourage his
former classmates to become politically
engaged, both on a state and national level.
He continues to practice independently in
Warrenton and Culpeper, Va.

Jon R. Friedman,
MD ’84, recently was
inducted as a fellow of
the American Society
of Transplantation
(AST) at the American
Transplant Congress in
Chicago and received
a Distinguished Service Award from the
AST in 2016. He is chief medical officer
for Optum’s Population Health Solutions
programs. Optum is the health services
division of UnitedHealth Group.

Elizabeth Reed Hanson, MD/GM ’07,
and Scott Hadland, MD ’09

Alumni honored
for teaching

T

he Academic Pediatrics
Association (APA) honored two
Washington University alumni at its
recent Pediatric Academic Society
meeting in San Francisco. Elizabeth
Reed Hanson, MD/GM ’07, assistant
professor/clinical and associate
program director of the Pediatric
Residency Program at the University
of Texas Health Science Center,
San Antonio, received the APA
Teaching Award for Faculty (Junior).
Scott Hadland, MD ’09, director of
the Urban Health and Advocacy
Track of the Boston Combined
Residency Program at Boston
Medical Center and Boston Children’s
Hospital, received the Residency
Teaching Program Award.
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James F. Loomis Jr., HS ’88, EMBA ’97,
recently moved to Washington, D.C.,
to become medical director at Barnard
Medical Center, a non-profit primary care
medical practice that focuses on nutrition
to help prevent, treat and reverse many
chronic diseases.

1990 S
Steve A. Harvey, LA ’88, MD ’92, HS ’96,
has been working to build TMS St. Louis,
a psychiatric subspecialty practice that
provides transcranial magnetic stimulation
(TMS) for patients with moderate or severe
treatment-refractory depression.
Ari Berkowitz, GM ’93, professor of
biology at the University of Oklahoma,
wrote and published a neurobiology book
for a general audience, titled “Governing
Behavior: How Nerve Cell Dictatorships and
Democracies Control Everything We Do,”
from Harvard University Press.

Ajay Ahuja, MD ’95, recently took a role at
Allergan Global as head of global and U.S.
medical affairs. Ahuja will move with his
family from Chicago to the New York City
area, where the company is headquartered.

teaching methods to seventh-12th grade
teachers in the Allentown school district.
Their children, Raphael, 14, and Julian,
10, are completing ninth and fifth grades,
respectively.

Michael Finley, PhD ’98, principal scientist
at Janssen R & D in Spring House, Pa., leads
a team of assay-development scientists
in a newly revitalized high-throughput
screening group for small-molecule
drug discovery. This supports a range of
therapeutic areas, including oncology,
immunology and neuroscience. Fellow
classmate and spouse, Audrey Ettinger,
PhD ’98, is completing a first sabbatical
semester after 15 years as a faculty member
at Cedar Crest College in Allentown, Pa.
In addition to her ongoing research and
teaching commitments, Ettinger serves as
an instructor in the Greater Allentown Math
Science Partnership to bring inquiry-based

Mary Iovine, PhD ’98,
recently was promoted
to professor at Lehigh
University in the
Department of
Biological Sciences.
Joni M. Kamiya, OT
’99, participated in
the 2015 Cornell Alliance for Science
Global Leadership Fellows Program to
help advocate for science-based policies
and access to technology. Kamiya lives in
Honolulu, and works professionally with
senior adults and people with disabilities.

Nonprofit empowers
Mexicans with disabilities

T

Clockwise from top left: William Neubauer,
MD ’69; Burris “Duke” Duncan, BA ’54, MD; and
wheelchair expert Gabriel Zepeda.

34 Washington University School of Medicine

wo Washington University alumni are helping hundreds of Mexican children and
adults with disabilities obtain affordable prosthetic limbs, all-terrain wheelchairs
and solar-powered hearing aids.
Realizing the great need for these devices among low-income Mexicans, Burris
“Duke” Duncan, BA ’54, MD, established the nonprofit company Arizona Sonora
Border Projects for Inclusion (ARSOBO) in 2012. William Neubauer, MD ’69, who
retired after 30 years as a general surgeon, now serves as the nonprofit’s board chair.
“If you lose a leg in Mexico, you are on crutches for life because prosthetics are
extremely expensive,” Neubauer said.
ARSOBO promotes self-sufficiency by training and employing individuals with
disabilities to construct medical equipment for themselves and others. These
individuals are charged only the cost of the device, or what they can afford. ARSOBO
recoups the remaining cost through charitable donations.
Neubauer has witnessed many miracles: adults who now work and lead normal
lives; an 8-year-old who learned to talk after getting a hearing aid; and formerly
homebound children with cerebral palsy who attend school.
“This is as important and satisfying to me as my 30 years in surgery,” Neubauer said.
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Rebecca S. Sippel,
MD ’99, associate
professor and chief
of the Division of
Endocrine Surgery
at the University of
Wisconsin-Madison, is
serving as president of
the Association for Academic Surgery
for the 2017-18 term.

2000 S
Jeffrey Henderson,
MD/PhD ’02, was
promoted to associate
professor of medicine
and molecular
microbiology at WUSM
and elected to the
American Society for
Clinical Investigation. Henderson also
received the Washington University
Outstanding Faculty Mentor Award from
the Graduate Student Senate.
Rachel Sieber, OT ’05, recently received a
post-professional doctorate in occupational
therapy from George Washington
University.
Cawas Engineer, PhD ’06, completed
a successful research project on crop
abiotic stress signaling at the University
of California, San Diego, and recently
accepted the role of director of research at
a start-up company in San Diego, where
he will lead research on sensory input
perception for drug discovery.
Keydra L. Oladapo, GM ’06, is currently
serving a four-year term as U.S. diplomat in
Southern Africa and received a promotion
to branch chief of epidemiology, surveillance,
monitoring and evaluation at the Centers
for Disease Control and Prevention.
Stacy Kruse, LA ’03, MD ’08, recently
returned to the U.S. with her husband and
3-year-old son, after two and a half years
of living in England. They have settled
near Washington, D.C., where Stacy is an
assistant professor of clinical medicine at
MedStar Georgetown University Hospital.
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Kimberly Dale, OT ’09, was selected to
participate in the Veterans Administration’s
Clinical and Administrative Leadership
Development Institute. This is a
competitive training and development
program aimed at building leadership
skills for higher roles in a health-care
system. Dale lives in Detroit.

2010 S
Tassy Hayden, LA ’07, MD ’11, is joining
the staffs of Southampton Healthcare in
St. Louis and BJC HealthCare. She looks
forward to aiding in the education of
WUSM students and serving the LGBT
and HIV-positive communities, particularly.
Aaron M. Bertoni, MD ’12, completed
residency training in anesthesia at the
University of Washington, Seattle, and
works part time at Island Hospital in
Anacortes, Wash. He spends the rest of
his time sailing the San Juan Islands,
hiking the Pacific Crest Trail and crabbing
in Puget Sound with his wife, Emily, and
dog, Barney.
Raghav Govindarajan,
HS ’13, recently gave
four invited talks and
was awarded the
Clerkship Director
Teaching Award, the
A.B. Baker Teacher
Recognition Award
and the Patient Safety Award by the
American Academy of Neurology at
its national meeting in Boston. He is
assistant professor of neurology at the
University of Missouri-Columbia School
of Medicine.
Louis Poppler, GM ’15, will begin a
fellowship at the Mayo Clinic for advanced
training in hand and nerve surgery.
Darlene R. (Gollaher) Tilley, PT ’15,
married Matthew Tilley, a student at
Covenant Theological Seminary, in
2016. She is celebrating two years of
employment at SSM Health Physical
Therapy and pursuing a certified
strength and conditioning specialty.

Robert C. Drews, MD ’55, a
professor emeritus of clinical
ophthalmology, former
member of the Board of
Trustees and university
benefactor, died Tuesday,
May 9, 2017, at his home in
St. Louis, following a stroke.
He was 86.
Drews was an ophthalmologist,
photographer, inventor of numerous
medical instruments for the eye, and
author of more than 500 journal articles,
book chapters and books.
“His expertise in lens implantation and
cataract surgery gained him international
recognition and numerous invitations to
teach advanced ophthalmic microsurgical
techniques all over the world,” said Todd P.
Margolis, MD, PhD, the Alan A. and Edith L.
Wolff Distinguished Professor and head of
the Department of Ophthalmology and
Visual Sciences.
Drews graduated from the School of
Medicine in 1955, did a residency in
ophthalmology from 1956 to 1959, and
became chief resident in 1958. After residency,
he entered the Navy, serving at the U.S. Naval
Hospital, Great Lakes, before returning to
St. Louis to go into private practice and teach
in the Department of Ophthalmology.
He is survived by his daughters Pamela
Breitberg (Steven), Belinda Laupp and Jeanmarie
Mertens (John); son, Carl Drews (Deborah); 10
grandchildren and eight great-grandchildren.
His wife, Lorene, preceded him in death.

Frederick D. Peterson, MD,
a former professor of clinical
pediatrics, died Thursday,
March 2, 2017, in his sleep
at a nursing home in
Chesterfield, Mo. He was 85.
A longtime influential
presence at St. Louis
Children’s Hospital, Peterson began his affiliation
with the university in 1957 as an intern and
ultimately ascended to professor of clinical
pediatrics in 1992. Peterson also maintained a
private practice for more than three decades.
Peterson is survived by his brother, William
Peterson, of Tallahassee, Fla.
continued on page 36 ...
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John M. Fredrickson,
MD, former head of
the Department of
Otolaryngology, died
Wednesday, April 5,
2017, in Vancouver,
Canada. He was 86.
Fredrickson came
to Washington University in 1982 to serve
as the Lindburg Professor and head of
the Department of Otolaryngology, a
position he held until 1998. He became
an emeritus professor in 2002.
Under Fredrickson’s leadership, the
department grew in both clinical and
research activities. His body of research
included major contributions to the fields
of vestibular neurophysiology, middle-ear
implants and microvascular reconstructive
surgery of the head and neck. After his
retirement in 2002, Fredrickson returned
to Vancouver and remained active in the
field, helping to develop an implantable
transducer for severe hearing loss.
Fredrickson is survived by his wife,
Alix, and his three children, Kristin, Lisa
and Erik Fredrickson.

Travis C. Mazer, a
doctoral candidate
studying molecular
genetics and genomics,
died unexpectedly
Monday, April 24, 2017,
in St. Louis. He was 25.
His research focused
on lysosomal biology in cellular stress and
homeostasis, with a goal of understanding
pathways to enhance cellular longevity. He
worked in the lab of Abhinav Diwan, MD, an
associate professor of medicine, and will be
listed as an author on an upcoming research
paper from Diwan’s lab.
Earlier, he worked for two years as a
research technician in the lab of Zachary
Pincus, PhD, an assistant professor of
developmental biology and genetics.
A Kalamazoo, Mich., native, Mazer
earned a bachelor’s degree in neuroscience
from the University of Michigan.
He is survived by his parents, Wendy and
Kevin Mazer; sisters, Mallory and Madison;
brothers, Taylor, Trent (Kaitlin) and Tate;
grandmothers, Jacqueline Roberts and Joyce
Griffin, plus many aunts, uncles and cousins.

Jean Holowach Thurston, MD, a pioneering pediatric neurologist,
died Saturday, April 29, 2017. She was 99 and about a month away
from her centennial birthday. Thurston died of natural causes at a
retirement home in University City, Mo.
A professor of pediatrics and of neurology, Thurston’s
influential research has guided treatment of childhood seizure
disorders. She led long-term studies examining anticonvulsant
withdrawal in pediatric patients with epilepsy. Thurston’s research,
published in 1972 in The New England Journal of Medicine, identified seizure
recurrence risks. Those findings, which remain relevant today, contributed to therapies
and diagnostic tools for childhood epilepsy.
Thurston continued her research for decades, establishing a neurochemistry lab,
publishing her last paper at age 78 and attending professional seminars until a year
before her death.
Thurston is survived by eight nieces. She was preceded in death by her husband
of 38 years, Donald L. Thurston, MD, a professor emeritus of pediatrics. The couple
collaborated on multiple research projects.

1940 S
Ernest J. Clark, MD ’48; Nov. ’16
Frank X. Dwyer, MD ’43; Feb. ’17
Robert H. Hall, MD ’45; March ’17
Dolores M. Moore, PT ’48; Feb. ’17
Betty Jo Petrofsky, NU ’48; Jan. ’17
Thomas E. Prosser III, DE ’45; April ’17
Clarence G. Schulz, MD ’45; Nov. ’16

1950 S
Eric I. Anderson, MD ’52; Jan. ’17
Ruth C. Comens, MD ’50; Feb. ’17
Henry R. Dallam Jr., DE ’54, GD ’64; Jan. ’17
Floyd M. Freeman, DE ’54; Feb. ’17
Dwayne R. Good, DE ’57; Dec. ’16
Howard R. Gray, MD ’52, HS; Feb. ’17
William G. McCuen, HS ’55; March ’17
Ralph B. Montgomery, DE ’54; March ’17
Marian P. Paxhia, NU ’57; March ’17
Jack Baer Rosen, LA ’55, DE ’58; March ’17
Raymond G. Schultze, LA ’55, MD ’59,
HS ’63; April ’17
Richard E. Thompson, MD ’59; Jan. ’17
Betty McKee Von Rump, PT ’58; Feb. ’17

1960 S
Henry E. Dupree, DE ’63; April ’17
Allan P. Fishbein, MD ’64; Sept. ’16
Koichi Fujii, HS ’62; March ’17
Gerald L. Howell, DE ’60; May ’17
Charles B. Manley, HS ’67; Nov. ’16
Thomas E. O’Keeffe, DE ’69; Feb. ’17
Nancy L. Pope, NU ’66; March ’17
Arthur Schneider, LA ’57, MD ’61; May ’17
Eli R. Shuter, MD ’60; April ’17
Thomas W. Yager, DE ’64; Feb. ’17

1970 S
Barry Miller Farr, MD ’78; Feb. ’17
Kay Miller Rusche, MD ’77; Feb. ’17
Ernest P. Sutton, DE ’73; April ’17
Anthony Weisenberger, MD ’71; March ’17

1980 S
Alexandre Carli, HS ’83; Jan. ’17
David Bradley Marrs, HS ’82; March ’17

2000 S
Aaron Rogat, PhD ’02; April ’17

For full obituaries, visit:
wumcnews.org/obits
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Magical moment

ROBERT BOSTON PHOTOS

Second-year medical student Hayley Motowski,
dressed as Belle from “Beauty and the Beast,”
presents a rose to Sarah Norwood, 9, of Arkansas,
who was awaiting surgery at St. Louis Children’s
Hospital. Students practicing for the 12th annual
School of Medicine musical — including (bottom,
from left) Molly Grabill as Mrs. Potts, Motowski,
Chase Elwood as the Beast and Philip Frasse as
Lumiere — took their act to the hospital. While
there, Motowski even demonstrated a proper
princess wave. Sarah’s mom, Sherri Norwood,
called the visit a welcome distraction.
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Witnessing history
The Washington University community
gathered at Ellen S. Clark Hope Plaza to watch
as the solar eclipse reached 99.99 percent
totality on the Medical Campus.
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